Evidence of the immunomodulatory role of dual PI3K/mTOR inhibitors in transplantation: an experimental study in mice

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Transplant International

• Publication date

  2017-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/tri.12989PMID 28543637
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sequential Targeting of CD52 and TNF Allows Early Minimization Therapy in Kidney Transplantation: From a Biomarker to Targeting in a Proof-Of-Concept Trial

  2017cited by this paper
• An integrated understanding of the immunology of allograft inflammation

  2017cited by this paper
• Discrete signaling mechanisms of mTORC1 and mTORC2: Connected yet apart in cellular and molecular aspects.

  2017cited by this paper
• Selective Sparing of Human Tregs by Pharmacologic Inhibitors of the Phosphatidylinositol 3‐Kinase and MEK Pathways

  2016cited by this paper
• Acute and Chronic Allograft Dysfunction in Kidney Transplant Recipients.

  2016cited by this paper
• Regulatory T cell expressed MyD88 is critical for prolongation of allograft survival

  2016cited by this paper
• In Vivo Expansion of Regulatory T Cells by Low-Dose Interleukin-2 Treatment Increases Allograft Survival in Corneal Transplantation

  2016cited by this paper
• Current views on chronic rejection after lung transplantation

  2015cited by this paper
• The imbalance between Tregs, Th17 cells and inflammatory cytokines among renal transplant recipients

  2015cited by this paper
• All-trans retinoid acid promotes allogeneic corneal graft survival in mice by regulating Treg-Th17 balance in the presence of TGF-β

  2015cited by this paper
• Th‐17 Alloimmune Responses in Renal Allograft Biopsies From Recipients of Kidney Transplants Using Extended Criteria Donors During Acute T Cell–Mediated Rejection

  2015cited by this paper
• The Critical Role of Induced CD4+ FoxP3+ Regulatory Cells in Suppression of Interleukin-17 Production and Attenuation of Mouse Orthotopic Lung Allograft Rejection

  2015cited by this paper
• mTOR Signaling in Regulatory T Cell Differentiation and Expansion

  2015cited by this paper
• Δ9‐Tetrahydrocannabinol attenuates allogeneic host‐versus‐graft response and delays skin graft rejection through activation of cannabinoid receptor 1 and induction of myeloid‐derived suppressor cells

  2015cited by this paper
• Hyperlipidemia Promotes Anti‐Donor Th17 Responses That Accelerate Allograft Rejection

  2015cited by this paper
• Rapamycin Prolongs Cardiac Allograft Survival in a Mouse Model by Inducing Myeloid‐Derived Suppressor Cells

  2015cited by this paper
• PI3K and cancer: lessons, challenges and opportunities

  2014cited by this paper
• The Ratio of Circulating Regulatory T Cells (Tregs)/Th17 Cells Is Associated with Acute Allograft Rejection in Liver Transplantation

  2014cited by this paper
• Administration of Low Doses of IL‐2 Combined to Rapamycin Promotes Allogeneic Skin Graft Survival in Mice

  2014cited by this paper
• Inhibition of the purinergic pathway prolongs mouse lung allograft survival.

  2014cited by this paper
• TGF-β–Mediated Foxp3 Gene Expression Is Cooperatively Regulated by Stat5, Creb, and AP-1 through CNS2

  2014cited by this paper
• Harnessing Regulatory T Cells for Clinical Use in Transplantation: The End of the Beginning

  2014cited by this paper
• The emerging role of TH17 cells in organ transplantation.

  2014cited by this paper
• Tolerance in Organ Transplantation: From Conventional Immunosuppression to Extracellular Vesicles

  2014cited by this paper
• Suppression of Feedback Loops Mediated by PI3K/mTOR Induces Multiple Overactivation of Compensatory Pathways: An Unintended Consequence Leading to Drug Resistance

  2014cited by this paper
• Once a Treg, always a Treg?

  2014cited by this paper
• mTORC1 couples immune signals and metabolic programming to establish Treg cell function

  2013influential reference
• A Dynamic Dual Role of IL-2 Signaling in the Two-Step Differentiation Process of Adaptive Regulatory T Cells

  2013cited by this paper
• Mitochondrial and cytosolic roles of PINK1 shape induced regulatory T‐cell development and function

  2013cited by this paper
• Fueling Immunity: Insights into Metabolism and Lymphocyte Function

  2013cited by this paper
• The balancing act of AKT in T cells

  2013cited by this paper
• Rapid effector function of memory CD8+ T cells requires an immediate-early glycolytic switch

  2013cited by this paper
• Regulatory T cells and transplantation tolerance.

  2013cited by this paper
• Crosstalk between mTOR complexes

  2013cited by this paper
• Developmental plasticity of murine and human Foxp3(+) regulatory T cells.

  2013cited by this paper
• Forkhead Transcription Factor FOXP3 Upregulates CD25 Expression through Cooperation with RelA/NF-κB

  2012cited by this paper
• The role of interleukin-2 during homeostasis and activation of the immune system

  2012cited by this paper
• mTOR, metabolism, and the regulation of T‐cell differentiation and function

  2012cited by this paper
• PKI-587 and sorafenib targeting PI3K/AKT/mTOR and Ras/Raf/MAPK pathways synergistically inhibit HCC cell proliferation.

  2012cited by this paper
• Generation of induced regulatory T cells from primary human naïve and memory T cells.

  2012cited by this paper
• Metabolic reprogramming and metabolic dependency in T cells

  2012cited by this paper
• Peripherally induced human regulatory T cells uncouple Kv1.3 activation from TCR‐associated signaling

  2011cited by this paper
• Antitumor Efficacy of PKI-587, a Highly Potent Dual PI3K/mTOR Kinase Inhibitor

  2011cited by this paper
• The mammalian Target of Rapamycin (mTOR) regulates T helper cell differentiation through the selective activation of mTORC1 and mTORC2 signaling

  2011cited by this paper
• Regulatory T cells and IL-17-producing cells in graft-versus-host disease.

  2011cited by this paper
• Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets

  2011influential reference
• Intragraft Regulatory T Cells in Protocol Biopsies Retain Foxp3 Demethylation and Are Protective Biomarkers for Kidney Graft Outcome

  2011cited by this paper
• PI-103 and sorafenib inhibit hepatocellular carcinoma cell proliferation by blocking Ras/Raf/MAPK and PI3K/AKT/mTOR pathways.

  2010cited by this paper
• Translational Mini‐Review Series on Th17 Cells: Development of mouse and human T helper 17 cells

  2010cited by this paper
• A comprehensive map of the mTOR signaling network

  2010cited by this paper
• Bis(morpholino-1,3,5-triazine) derivatives: potent adenosine 5'-triphosphate competitive phosphatidylinositol-3-kinase/mammalian target of rapamycin inhibitors: discovery of compound 26 (PKI-587), a highly efficacious dual inhibitor.

  2010cited by this paper
• Inflammation and the balance of Treg and Th17 cells in transplant rejection and tolerance

  2010cited by this paper
• Alloantigen specific T regulatory cells in transplant tolerance.

  2009cited by this paper
• TORC-specific phosphorylation of mammalian target of rapamycin (mTOR): phospho-Ser2481 is a marker for intact mTOR signaling complex 2.

  2009cited by this paper
• mTOR Ser-2481 Autophosphorylation Monitors mTORC-specific Catalytic Activity and Clarifies Rapamycin Mechanism of Action*

  2009cited by this paper
• T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR

  2008cited by this paper
• DNA methylation controls Foxp3 gene expression

  2008cited by this paper
• Combination of rapamycin and IL-2 increases de novo induction of human CD4(+)CD25(+)FOXP3(+) T cells.

  2008cited by this paper
• Pharmacologic characterization of a potent inhibitor of class I phosphatidylinositide 3-kinases.

  2007cited by this paper
• IL-2 Receptor β-Dependent STAT5 Activation Is Required for the Development of Foxp3+ Regulatory T Cells1

  2007cited by this paper
• Regulatory T cells and transplantation tolerance.

  2006cited by this paper
• FOXP3: of mice and men.

  2006cited by this paper
• Rapamycin Promotes Expansion of Functional CD4+CD25+FOXP3+ Regulatory T Cells of Both Healthy Subjects and Type 1 Diabetic Patients1

  2006cited by this paper
• Inhibition of donor‐derived T cells trafficking into target organs by FTY720 during acute graft‐versus‐host disease in small bowel transplantation

  2006cited by this paper
• A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma.

  2006cited by this paper
• The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells.

  2006cited by this paper
• Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB.

  2006cited by this paper
• Prolonged TCR/CD28 Engagement Drives IL-2-Independent T Cell Clonal Expansion through Signaling Mediated by the Mammalian Target of Rapamycin1

  2006cited by this paper
• Benefit-Risk Assessment of Sirolimus in Renal Transplantation

  2005cited by this paper
• Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex

  2005cited by this paper
• Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells.

  2005cited by this paper
• Of Mice and Not Men: Differences between Mouse and Human Immunology

  2004cited by this paper
• GSK-3: tricks of the trade for a multi-tasking kinase

  2003influential reference
• CD28 Costimulation Mediates T Cell Expansion Via IL-2-Independent and IL-2-Dependent Regulation of Cell Cycle Progression1

  2000influential reference
• Scoring of skin rejection in a swine composite tissue allograft model.

  1999cited by this paper
• Activity of rapamycin (AY-22,989) against transplanted tumors.

  1984cited by this paper
• The Orphan Nuclear Receptor ROR g t Directs the Differentiation Program of Proinflammatory IL-17 + T Helper Cells

  year unknowncited by this paper

• Phosphatidylinositol‐4,5‐bisphosphate 3‐kinase (PI3K) inhibitors reduce vascular inflammation in vitro and in vivo

  2025cites this paper
• Effect of mitochondrial oxidative stress on Regulatory T Cell manufacturing for clinical application in transplantation: results from a pilot study.

  2024cites this paper
• mTOR Inhibition Impairs the Activation and Function of Belatacept-Resistant CD4+CD57+ T Cells In Vivo and In Vitro

  2023cites this paper
• Metabolic Disruption Induced by mTOR Signaling Pathway Inhibition in Regulatory T-Cell Expansion for Clinical Application

  2023influential citation
• Anti-neoplastic sulfonamides alter the metabolic homeostasis and disrupt the suppressor activity of regulatory T cells

  2022cites this paper
• PI3K in T Cell Adhesion and Trafficking

  2021cites this paper
• Targeting peripheral immune organs with self‐assembling prodrug nanoparticles ameliorates allogeneic heart transplant rejection

  2021cites this paper
• AICAR prolongs corneal allograft survival via the AMPK-mTOR signaling pathway in mice.

  2019cites this paper
• mTOR Inhibitor Everolimus in Regulatory T Cell Expansion for Clinical Application in Transplantation

  2019cites this paper
• Peptide Tk‐PQ induces immunosuppression in skin allogeneic transplantation via increasing Foxp3+ Treg and impeding nuclear translocation of NF‐&kgr;B

  2018cites this paper